Methamphetamine use and rates of incarceration among street-involved youth in a Canadian setting: a cross-sectional analysis by Milloy, M-J et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Substance Abuse Treatment, 
Prevention, and Policy
Open Access Research
Methamphetamine use and rates of incarceration among 
street-involved youth in a Canadian setting: a cross-sectional 
analysis
M-J Milloy†1,2, Thomas Kerr†1,4, Jane Buxton†2,3, Julio Montaner†1,4 and 
Evan Wood*†1,4
Address: 1BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada , 2School of 
Population and Public Health, University of British Columbia, 5804 Fairview Avenue, Vancouver, BC, V6T 1Z3, Canada , 3Department of 
Epidemiology, BC Centre for Disease Control, 655 12th Avenue West, Vancouver, BC, V5Z 4R4, Canada  and 4Department of Medicine, University 
of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada 
Email: M-J Milloy - mjmilloy@cfenet.ubc.ca; Thomas Kerr - uhri-tk@cfenet.ubc.ca; Jane Buxton - jane.buxton@bccdc.ca; 
Julio Montaner - jmontaner@cfenet.ubc.ca; Evan Wood* - uhri-ew@cfenet.ubc.ca
* Corresponding author    †Equal contributors
Abstract
Background: Given concerns over rising use of methamphetamine, especially among street-
involved youth, and the links between exposure to the correctional system and the production of
drug-related harm, we sought to assess the relationship between ever using methamphetamine and
reporting ever being incarcerated in the At-Risk Youth Survey (ARYS) in Vancouver, Canada.
Methods: The relationship between ever being imprisoned and ever using methamphetamine was
estimated using a multivariate logistic regression analysis while also considering potentially
confounding secondary demographic, social and behavioural variables.
Results: Of the 478 youth recruited into ARYS between September 2005 and October 2006, 385
(80.5%) reported ever being incarcerated overnight or longer. In the multivariate model,
methamphetamine use was independently associated with ever being incarcerated (Adjusted Odds
Ratio: 1.79, 95% Confidence Interval [CI]: 1.03 – 3.13).
Conclusion: Incarceration was very common in this cohort and strongly linked with ever using
methamphetamine. This finding is of concern and, along with the previously identified risks of drug-
related harm associated with incarceration, supports the development of novel public policy, such
as community-based drug treatment, to address the use of methamphetamine among street youth.
Background
The use of methamphetamine in Western settings is of
increasing concern [1,2], especially among street-involved
youth [3,4], a vulnerable population already burdened by
high levels of morbidity and mortality [5,6]. According to
the United Nations Office on Drugs and Crime, metham-
phetamine now constitutes the second most commonly
used illicit drug internationally, second only to marijuana
[7].
For older drug users, especially those who use injection
drugs (IDU), the dynamics linking drug use, marginalisa-
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tion and imprisonment are well described [8-10]. Arrest
and imprisonment is a common experience, with a his-
tory of incarceration reported by at least 75% of partici-
pants in community-recruited samples of IDU in Europe
[11], Thailand [12] and the United States [13]. Incarcera-
tion may be a risk factor for drug related harm among
IDU, since exposure to correctional environments has
consistently been associated with an increased likelihood
of HIV risk behavior and HIV infection [14,15] as well as
increased risk of fatal overdose upon release [16].
Sparked by the growing use of methamphetamine and
concerns over links to initiation of injection drug use [17],
we have previously reported that over 75% of participants
in a local cohort of street-involved youth said they had
previously used methamphetamine [4]; 25% of all injec-
tion initiation experiences involved methamphetamine
[4]; and 13% of local overdose events among homeless
youth involve the use of methamphetamine [18]. Vancou-
ver is the site of an explosive outbreak of HIV among IDU
with current prevalence estimated at 20% [19]; approxi-
mately 3% of local street youth are estimated to be HIV-
seropositive [20]. Since exposure to the criminal justice
system through arrest and incarceration may actually
increase drug-related harms [15], we conducted the
present study to determine the prevalence of incarceration
in a cohort of community-recruited street youth and
investigate its relationship with the use of methampheta-
mine.
Methods
The At-Risk Youth Study (ARYS) is a prospective cohort of
street-involved youth in Vancouver, Canada, that has
been described in detail previously [17]. In brief, snow-
ball sampling and street-based outreach were used in an
effort to derive a representative sample of street-involved
drug using youth. Individuals were eligible for inclusion if
they were aged 14 to 26 years old at the baseline interview
and had used illegal drugs other than cannabinoids in the
previous 30 days. At baseline and every six-month follow-
up, participants answer an interviewer-administered ques-
tionnaire, are examined by a nurse and provide blood
samples for serologic testing. The ARYS study has been
reviewed and approved by the University of British
Columbia/Providence Research Ethics Board.
For the present analyses, the outcome of interest was
reporting ever being incarcerated, or answering "yes" to
the question: "Have you ever been in detention, prison,
the drunk tank or jail overnight or longer?" The primary
explanatory variable of interest was reporting ever using
methamphetamine. First, we compared individuals
reporting incarceration with those reporting never incar-
cerated using individual-, social- and structural-level fac-
tors we hypothesised could be associated with both the
outcome of interest and primary explanatory variable.
These secondary explanatory variables included: gender;
age; ethnicity (Non-aboriginal vs. aboriginal); education
level (< high school vs. ≥ high school); history of foster
care (yes vs. no); history of ER use (yes vs. no); hepatitis C
virus (HCV) seropositivity (yes vs. no); ever involved in
the sex-trade (yes vs. no); ever diagnosed with a mental ill-
ness (yes vs. no); ever dealing drugs (yes vs. no); ever
being sexually or physically abused (yes vs. no); ever using
crack cocaine (yes vs. no); ever using powder cocaine (yes
vs. no); ever injecting heroin (yes vs. no); ever using can-
nibinoids (i.e., marijuana, hashish) (yes vs. no). All drug
use variables referred to any prior use.
For univariate analyses, we used Pearson's χ2 test (dichot-
omous variables) and the Mann-Whitney test (continuous
variables) to compare individuals reporting the outcome
versus others by the primary and secondary explanatory
variables. To fit the multivariate model, we employed a
backwards selection procedure we have used previously
[21,22]. After beginning with a full model with all covari-
ates included, we fit reduced models, each with one
unique secondary explanatory variable removed, and
observed in each model the relative change in the coeffi-
cient for the term for methamphetamine in the regression
equation. We identified the reduced model with the
smallest absolute relative change in the methampheta-
mine coefficient and removed its missing secondary vari-
able from further consideration. The objective of this step
is to remove variables with relatively less effect on the
value of the coefficient for methamphetamine and, with
each step, to preserve variables in the analysis with greater
infuence on the value of the methamphetamine coeffi-
cient in multivariate analysis. We continued this iterative
process until the smallest relative change in the metham-
phetamine coefficient exceeded 5% of the value of the
coefficient. We then fit a final model including metham-
phetamine use and all remaining secondary explanatory
variables as terms in the regression equation.
All statistical analyses were performed in R version 2.6.1
(R Foundation for Statistical Computing, Vienna, Aus-
tria). All p-values are two-sided.
Results
Between September 2005 and October 2006, 478 individ-
uals were recruited into the ARYS cohort, of whom 132
(27.6%) were female, 120 (25.1%) reported Aboriginal
ancestry and 329 (68.8%) were Caucasian. At the baseline
interview, the median age was 22.0 (Interquartile Range
[IQR]: 20.0 – 23.9).
Of the 478 participants, 385 (80.5%) reported ever being
incarcerated. As shown in Table 1, social and demo-
graphic characteristics associated with incarceration inSubstance Abuse Treatment, Prevention, and Policy 2009, 4:17 http://www.substanceabusepolicy.com/content/4/1/17
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univariate analyses were: older age (Odds Ratio [OR]:
1.23, 95% Confidence Interval [95% CI]: 1.17 – 1.28, p <
0.001); having less than a high school education (OR:
1.66, 95% CI: 1.04 – 2.66, χ2 = 4.07 [df = 1], p = 0.032);
and ever being a victim of abuse (OR: 2.10, 95% CI: 1.32
– 3.34, χ2 = 9.24 [df = 1], p = 0.002). Female gender was
inversely associated with having a history of incarceration
(OR: 0.19, 95% CI: 0.12 – 0.31, χ2 = 48.03 [df = 1], p <
0.001). Behavioural and drug-using variables associated
with a history of incarceration are shown in Table 2 and
included: methamphetamine use (OR: 2.45, 95% CI: 1.53
– 3.90, χ2 = 13.53 [df = 1], p < 0.001); crack use (OR: 3.08,
95% CI: 1.89 – 5.03, χ2 = 20.12 [df = 1], p  < 0.001);
cocaine use (OR: 2.49, 95% CI: 1.33 – 4.66, χ2 = 8.02 [df
= 1], p = 0.003); and drug dealing (OR: 3.19, 95% CI: 1.97
– 5.19, χ2 = 22.03 [df = 1], p < 0.001).
Results from the final multivariate logistic regression
model are displayed in Table 3. The primary explanatory
variable, previous use of methamphetamine, was inde-
pendently associated with ever being incarcerated in a
model which included foster care, female gender, Aborig-
inal ethnicity and crack use. Correlation between the
explanatory variables was moderate, ranging from 0.00 to
0.35.
Discussion
In this survey of street-involved youth in Vancouver, Can-
ada, we observed a high level of both ever being incarcer-
ated and ever using methamphetamine. The level of
incarceration observed in this sample (80.5%) is substan-
tially higher than other estimates in surveys of street-
involved youth. In 2004, a multi-site cross-sectional study
of 1733 Canadian street youth reported 784 (45.2%) had
been in jail [23]. A similar level was reported by 536
homeless youth in Portland, Oregon [24]. In our setting,
this level of incarceration is higher (80.5% vs. 59.4%)
than that observed in a cohort of adult IDU recruited from
a local harm reduction facility [15]. Reasons for this
heightened level might include, proximally, the preva-
lence of high-intensity drug use and involvement in the
sex trade; and, ultimately, social and structural factors
including a dearth of affordable housing and ordnances
targeting homeless individuals [25,26].
Table 1: Univariate analyses of social and demographic characteristics associated with reporting ever being incarcerated in ARYS (n = 478)
Ever incarcerated
Characteristic No (%) Yes (%) Odds Ratio 95% Confidence Interval p-value1
Age (df = 476)
Median (IQR) 20.8 (17.7 – 23.4) 22.4 (18.4 – 26.3) 1.23 1.17 – 1.28 < 0.001
Gender (df = 1)
Male 40 (43.0) 306 (79.5)
Female 53 (57.0) 79 (20.5) 0.19 0.12 – 0.31 < 0.001
Ethnicity (df = 1)
Non-Aboriginal 76 (81.7) 282 (73.2)
Aboriginal 17 (18.2) 103 (26.8) 1.63 0.92 – 2.89 0.091
Education (df = 1)
≥ High school 38 (40.9) 113 (29.4)
< High school 55 (59.1) 272 (70.6) 1.66 1.04 – 2.66 0.032
Foster care2 (df = 1)
No 52 (55.9) 183 (47.5)
Yes 41 (44.1) 202 (52.5) 1.40 0.89 – 2.21 0.147
HCV status (df = 1)
Negative 77 (82.8) 339 (88.1)
Positive 16 (17.2) 46 (11.9) 0.65 0.35 – 1.21 0.176
Mental illness2 (df = 1)
No 59 (63.4) 225 (58.4)
Yes 34 (36.6) 160 (41.6) 1.23 0.77 – 1.97 0.378
Victim of abuse2 (df = 1)
No 58 (62.4) 170 (44.2)
Yes 35 (37.6) 215 (55.8) 2.10 1.32 – 3.34 0.002
ER use2 (df = 1)
No 61 (65.6) 225 (58.4)
Yes 32 (34.4) 160 (41.6) 1.36 0.84 – 2.18 0.239
1. p-values based on χ-square tests of difference (for categorical variables) and the Mann-Whitney test (for continuous)
2. Refers to any instance in the pastSubstance Abuse Treatment, Prevention, and Policy 2009, 4:17 http://www.substanceabusepolicy.com/content/4/1/17
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Although several street youth surveys include contact with
the criminal justice system as an explanatory covariate
[23,27,28], we are unaware of any study that identifies the
factors associated with incarceration among street-
involved youth. In the present study, we found metham-
phetamine use to be independently associated with ever
being incarcerated after adjustment for a number of possi-
ble social, demographic and behavioural confounders.
Since it is not possible to resolve the temporal relation-
ship between the dependent and primary explanatory var-
iable in a cross-sectional analysis, we hypothesise the
association is most likely the result of methamphetamine
use, and the means required to support it (e.g., sex trade
involvement and other criminal activity) increasing the
visibility of street youth to police, elevating the risk of
arrest and imprisonment. However, the possibility that
methamphetamine use is a sequelae of imprisonment for
some individuals cannot be excluded. Numerous studies
report a shift to higher-intensity drug use, for example the
initiation of drug use by injection, upon incarceration
[12,29,30]. Similarly, in a sample of 569 street-involved
young men who have sex with men in New York City, con-
tact with the criminal justice system was most often found
to precede beginning to use drugs such as heroin, cocaine
and speed as well as involvement in the sex trade [30]. In
a detailed qualitative analysis, Vancouver street-involved
youth described the multiple ways methamphetamine use
helped them cope with their social and environmental cir-
cumstances, including mediating social contacts, main-
taining vigilance over themselves and their possessions,
and avoiding the use of psychiatric medications [29].
Regardless of whether methamphetamine use is a predic-
tor or sequelae of incarceration, the strong independent
association observed between its use and imprisonment
in this analysis is cause for concern. As a result of the per-
Table 2: Univariate analyses of behavioural and drug-using characteristics associated with reporting ever being incarcerated in ARYS 
(n = 478)
Ever incarcerated
Characteristic No (%) Yes (%) Odds Ratio 95% Confidence Interval p-value1
Methamphetamine use2 (df = 1)
No 42 (45.2) 97 (25.2)
Yes 51 (54.8) 288 (74.8) 2.45 1.53 – 3.90 < 0.001
Crack use2 (df = 1)
No 37 (39.8) 68 (17.7)
Yes 56 (60.2) 317 (82.3) 3.08 1.89 – 5.03 < 0.001
Heroin injection2 (df = 1)
No 74 (79.7) 269 (69.9)
Yes 19 (20.4) 116 (30.1) 1.68 0.97 – 2.90 0.062
Cocaine use2 (df = 1)
No 80 (86.0) 274 (71.1)
Yes 13 (14.0) 111 (28.9) 2.49 1.33 – 4.66 0.003
Cannabinoid use2 (df = 1)
No 8 (8.6) 19 (4.9)
Yes 85 (91.4) 366 (93.1) 1.81 0.76 – 4.28 0.169
Drug dealing2 (df = 1)
No 39 (41.9) 71 (18.4)
Yes 54 (58.1) 314 (81.6) 3.19 1.97 – 5.19 < 0.001
Sex trade2 (df = 1)
No 77 (82.8) 305 (79.2)
Yes 16 (17.2) 80 (20.8) 1.26 0.70 – 2.28 0.440
1. p-value based on results of χ-square test of difference
2. Refers to any time in the past
Table 3: Multivariate logistic regression analysis of primary and secondary factors associated with reporting ever being incarcerated in 
ARYS (n = 478)
Characteristic Adjusted Odds Ratio 95% Confidence Interval p-value2
Methamphetamine use1 (yes vs. no) 1.79 1.03 – 3.13 0.041
Foster care1 (yes vs. no) 1.58 0.94 – 2.65 0.081
Gender (Female vs. male) 0.17 0.10 – 0.28 < 0.001
Ethnicity (Aboriginal vs. non-Aboriginal) 1.69 0.89 – 3.18 0.107
Crack use1 (yes vs. no) 2.45 1.38 – 4.32 0.002
1. Refers to any time in the pastSubstance Abuse Treatment, Prevention, and Policy 2009, 4:17 http://www.substanceabusepolicy.com/content/4/1/17
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sistence of drug use by many prisoners [31] alongside the
lack of harm reduction and addiction treatment opportu-
nities within correctional environments [31], exposure to
correctional environments has been linked to a higher risk
for infection with blood-borne pathogens, including HIV,
in this setting [15] as others [32,33]. Thus, the frequent
imprisonment of street youth who inject methampheta-
mine could help sustain viral transmission in this popula-
tion. Although future work should investigate the
relationship between contact with police, courts and jails
and intake into alcohol and drug treatment programmes
for young drug users, the brief sentences typically served
by those designated young offenders suggests little reha-
bilitative care is available [34]. These factors support the
development of novel public policies to address metham-
phetamine use. We recognise that a substantial segment of
policymakers as well as the general public supports puni-
tive sanctions for illicit drug use as a signal of social disap-
proval as well as a disincentive for current or future use.
However, we note that little empiric evidence exists of the
effectiveness of this approach on either the individual or
population level despite the investment of significant
public funds [35]. Thus, our findings add support to calls
for new policy approaches to curb illicit drug use among
members of the population, for example community
diversion or expanded access to drug treatment. Some
new programmes to address methamphetamine use, espe-
cially in the United States, have been developed, includ-
ing education and public awareness and precursor
regulation [36,37]. These initiatives should be rigourously
evaluated before being applied to a vulnerable popula-
tion.
We also observed a high prevalence of ever using crack
cocaine in this cohort, with 78.0% of participants report-
ing ever using the drug. In the univariate analysis, crack
cocaine use was strongly associated with ever being incar-
cerated (p < 0.001). While the effect measures of second-
ary adjusting variables included in confounding models
should be interpreted with caution, it is clear that there is
a strong and likely independent effect of crack cocaine use
increasing the likelihood of incarceration. The link
between high-intensity cocaine use and a greater likeli-
hood of drug-related harms, including incarceration, has
been well described in this and other settings. Recently,
we reported a high level of crack use in this cohort
strongly linked with homelessness [38]. Previous research
from Vancouver determined that stimulant use, including
cocaine and methamphetamine, helps individuals cope
with the immediate rigours of street-involved life, includ-
ing diminishing feelings of hunger, improving wakefull-
ness and awareness and reducing boredom [29,38].
This analysis has some limitations which should be
addressed. As random sampling methods could not be
employed due to a lack of voters' lists or other registries,
findings from this population of street-involved youth
might not be generalisable to the entire local street youth
population or other settings. However, it is noteworthy
the demographic composition of ARYS is similar to other
street-youth samples in Vancouver [3,39]. Second, several
measures rely on self-report; thus, social desirability bias
might have led to an underestimate of the prevalence of
some variables. However, we do not believe any bias was
differentially reported by history of incarceration. Finally,
we were unable to consider the effect of different dura-
tions or locations of incarceration nor did we gather infor-
mation on the age at first incarceration; also, the cohort
contains individuals possibly exposed to either youth
detention centres, adult facilities, or both. Future research
should consider the effect of these modifiers on drug use
patterns and other concerns.
Conclusion
To conclude, this is the first study to describe such high
rates of incarceration among street involved youth and to
explore risk factors for incarceration among this popula-
tion. In multivariate regression analysis including several
possible confounders, reporting a history of incarceration
was strongly associated with ever using methampheta-
mine. Given the rising prevalence of methamphetamine
use in this area as others, and the elevated risk for drug-
related harms including HIV infection associated with
exposure to correctional environments, these findings
support the development of new public policy to support
the health of drug-using and street-involved youth, and
the exploration of community diversion programs (e.g.
addiction treatment) to avoid the high rates of incarcera-
tion among this population.
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